The European Commission has urged UK Pharma firms to check how Brexit will impact their drugs, pointing out that EU law requires that authorisation holders have a base in a member state or EEA country.
The EMA has said it will assess Samsung Bioepis’ version of Humira (adalimumab), which is the third biosimilar the (currently) London-based agency has accepted for review.
GE Healthcare owner General Electric says it did not authorise pro-Brexit campaigners to use its logo and has reitered its support for the UK's membership of the European Union.
A downstream centre in Scotland will allow local biotechs to test product scale-up without outsourcing overseas, while complementing other Government-funded bioprocessing projects in the UK.
The UK Bioindustry Association (BIA) has set out a vision to create a biotech cluster which could compete in size and scale against hubs in Massachusetts and California.
UK packaging equipment supplier Isopak has introduced an all-in-one
system designed to eliminate the difficulties of handling and
packing pharmaceuticals, foods and cosmetics in sachets.
